08329.HK
Shenzhen Neptunus Interlong Bio-technique Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 0.10
−6.36%Leverage
- Debt / equity
- 0.15x
- Net debt / equity
- -0.18x
- Debt / assets
- 0.09x
- Debt / EBITDA
- 1.55x
- Net debt / EBITDA
- -1.86x
Liquidity & coverage
- Current ratio
- 2.00x
- Quick ratio
- 1.50x
- Cash ratio
- 0.64x
- Interest coverage
- -10.35x
- EBITDA / interest
- 12.02x
- Working capital
- HKD 391.7M
Cash & dividend
- FCF / debt
- 1.38x
- Cash flow / debt
- 1.50x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026